Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
5 drugs for “Advanced Non-Small-Cell Lung Cancer”
Approved 1
- CemiplimabREGENERON PHARMACEUTICALS, INC.Advanced Non-Small Cell Lung Cancer
Phase 3 4
- FianlimabREGENERON PHARMACEUTICALS, INC.Advanced Non-Small Cell Lung Cancer
- FirmonertinibArriVent BioPharma, Inc.Advanced Non-Small-Cell Lung Cancer
- FurmonertinibArriVent BioPharma, Inc.Advanced Non-Small Cell Lung Cancer
- MRTX849Mirati Therapeutics, Inc.Advanced Non Small Cell Lung Cancer
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.